ReAlta Life Sciences
Sam is an accomplished peptide chemist and consultant with 30+ years of strategic leadership and manufacturing experience. He is the founder and former CEO of New England Peptide (NEP), a worldwide leader in peptide and antibody production. Sam has held scientific positions at multiple peptide and antibody corporations including Quality Controlled Biochemicals, Leukosite, Repligen, NEP, Excipio, and Sigma Genosys. His executive experience includes multiple scientific acquisitions and divestitures as well as peptide design consultation with biotechnology firms worldwide.
Sam was honored by the Worcester Business Journal as a “40 under 40” recipient, and his corporation NEP won “Start-Up of the Year” in Central Massachusetts in 1999 and “2020 Manufacturer of the Year”. Sam graduated Magna Cum Laude from the Honors Program at Northeastern University with B.S. in Biology.
This person is not in the org chart
This person is not in any offices
ReAlta Life Sciences
ReAlta Life Sciences, Inc. is an early stage pharmaceutical company incorporated in late, 2018, and located in Norfolk, Virginia. ReAlta was initially formed as a joint venture between Children’s Hospital of The King’s Daughters, Children’s Specialty Group (170 multispecialty pediatricians) and Eastern Virginia Medical School. ReAlta is dedicated to addressing life-threatening medical needs through beneficial inhibition of the Complement System and Inflammatory Mechanisms. To support this mission, ReAlta has developed a New Class of Drugs that can address unmet medical needs through unique Multi-Modal Therapeutic Capabilities.